
doi: 10.1007/bf02722596
pmid: 11758133
Apnea, defined as cessation of breathing resulting in pathological changes in heart rate and oxygen saturation, is a common occurrence in sick neonates. Apnea is a common manifestation of various etiologies in sick neonates. In preterm children it may be related to the immaturity of the central nervous system. Secondary causes of apnea should be excluded before a diagnosis of apnea of prematurity is made. Methylaxanthines and Continuous Positive Airway Pressure form the mainstay of treatment of apnea in neonates. Mechanical ventilation is reserved for apnea resistant to above therapy. An approach to the management of apnea in neonates has been described.
Apnea, Infant, Newborn, Infant, Premature, Diseases, Aminophylline, Respiration, Artificial, Bronchodilator Agents, Positive-Pressure Respiration, Caffeine, Humans, Central Nervous System Stimulants, Infant, Premature
Apnea, Infant, Newborn, Infant, Premature, Diseases, Aminophylline, Respiration, Artificial, Bronchodilator Agents, Positive-Pressure Respiration, Caffeine, Humans, Central Nervous System Stimulants, Infant, Premature
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
